Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2008-02-29 08:00 |
Pharming concludes license agreement with Advanced Cell Technology
|
English | 68.0 KB | ||
| 2008-02-29 08:00 |
Pharming concludes license agreement with Advanced Cell Technology
|
English | 69.6 KB | ||
| 2008-02-15 08:29 |
Pharming announces annual results 2007
|
English | 115.4 KB | ||
| 2008-02-15 08:29 |
Pharming announces annual results 2007
|
English | 111.6 KB | ||
| 2007-12-21 12:48 |
PHARMING SUBMITS REQUEST FOR RE-EXAMINATION OF CHMP OPINION FOR EUROPEAN MARKET…
|
English | 73.2 KB | ||
| 2007-12-17 08:08 |
PHARMING STARTS COLLABORATION WITH SOLVAY AND ACADEMIC GROUPS ON PARKINSON AND …
|
English | 82.2 KB | ||
| 2007-12-17 08:08 |
PHARMING STARTS COLLABORATION WITH SOLVAY AND ACADEMIC GROUPS ON PARKINSON AND …
|
English | 76.7 KB | ||
| 2007-12-13 17:19 |
Pharming prepares to appeal ruling on European Marketing Authorization Applicat…
|
English | 77.6 KB | ||
| 2007-11-02 08:39 |
Pharming to present at Acumen BioFin Rodman & Renshaw Healthcare Conference
|
English | 67.0 KB | ||
| 2007-11-02 08:39 |
Pharming to present at Acumen BioFin Rodman & Renshaw Healthcare Conference
|
English | 70.6 KB | ||
| 2007-10-29 13:18 |
Pharming announces completion of randomized treatments in North American clinic…
|
English | 75.3 KB | ||
| 2007-10-19 08:33 |
Pharming announces third quarter 2007 results
|
English | 48.8 KB | ||
| 2007-10-19 08:33 |
Pharming announces third quarter 2007 results
|
English | 47.1 KB | ||
| 2007-10-19 08:33 |
Pharming raises 70 million euro through the issue of convertible bonds
|
English | 20.7 KB | ||
| 2007-10-19 08:33 |
Pharming raises 70 million euro through the issue of convertible bonds
|
English | 21.6 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
